Drug delivery to the retina: challenges and opportunities
暂无分享,去创建一个
[1] M. Refojo,et al. Biodegradable microspheres for vitreoretinal drug delivery. , 2001, Advanced drug delivery reviews.
[2] H. Takanaga,et al. Immunohistochemical and Functional Characterization of pH‐dependent Intestinal Absorption of Weak Organic Acids by the Monocarboxylic Acid Transporter MCT1 , 1999, The Journal of pharmacy and pharmacology.
[3] L. Wheeler,et al. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. , 2002, Drug Metabolism And Disposition.
[4] L. Drewes,et al. Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina , 1999, Neuroscience.
[5] H F Edelhauser,et al. Transscleral drug delivery for posterior segment disease. , 2001, Advanced drug delivery reviews.
[6] H. Saito,et al. Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1 , 1996, FEBS letters.
[7] A Hatefi,et al. Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[8] A. Mitra,et al. Ocular pharmacokinetics of cephalosporins using microdialysis. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[9] M. Kilberg,et al. Recent advances in mammalian amino acid transport. , 1993, Annual review of nutrition.
[10] J. Robinson,et al. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[11] H. Daniel,et al. Transport of beta-lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide/H+ symporter. , 1993, The Journal of clinical investigation.
[12] N. Philp,et al. Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium. , 1997, Biochemical and biophysical research communications.
[13] M. Hediger,et al. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system , 1999, Anatomy and Embryology.
[14] A. Mitra,et al. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. , 2001, Experimental eye research.
[15] F. J. Romero,et al. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients , 1992, Documenta Ophthalmologica.
[16] V. Lee. Membrane transporters. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] Y. Ogura,et al. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. , 2001, Investigative ophthalmology & visual science.
[18] H. Takanaga,et al. Nicotinic Acid Transport Mediated by pH‐dependent Anion Antiporter and Proton Cotransporter in Rabbit Intestinal Brush‐border Membrane , 1996, The Journal of pharmacy and pharmacology.
[19] Daniel F. Martin,et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. , 2002, The New England journal of medicine.
[20] J. Shaw,et al. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. , 1996, Current eye research.
[21] S. D. Bustros,et al. Treatment of cytomegalovirus retinitis with ganciclovir. , 1987, Ophthalmology.
[22] D. Mochly‐Rosen,et al. Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). , 2001, Chemistry & biology.
[23] A. Skarin,et al. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[24] S. Dieck,et al. The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative beta-Ala-Lys-Nepsilon-AMCA in astrocytes. , 1999, Glia.
[25] V. Ganapathy,et al. Expression and Differential Polarization of the Reduced-folate Transporter-1 and the Folate Receptor α in Mammalian Retinal Pigment Epithelium* , 2000, The Journal of Biological Chemistry.
[26] P. Ashton,et al. Sustained-release subconjunctival 5-fluorouracil. , 1996, Ophthalmic surgery and lasers.
[27] P. Low,et al. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[28] A. Mitra,et al. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[29] J. Diamond. Intraocular management of endophthalmitis. A systematic approach. , 1981, Archives of ophthalmology.
[30] L. Benet,et al. Comparison of Bidirectional Cephalexin Transport Across MDCK and Caco-2 Cell Monolayers: Interactions with Peptide Transporters , 2004, Pharmaceutical Research.
[31] G. Peyman,et al. Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. , 1982, Survey of ophthalmology.
[32] W. Thoreson,et al. Expression of Multidrug Resistance-Associated Protein (MRP) in Human Retinal Pigment Epithelial Cells and Its Interaction with BAPSG, a Novel Aldose Reductase Inhibitor , 2001, Pharmaceutical Research.
[33] T. Terasaki,et al. Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. , 1991, The Journal of pharmacology and experimental therapeutics.
[34] D. Maurice,et al. Review: practical issues in intravitreal drug delivery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[35] J. Kim,et al. Identification and Characterization of a Na+-independent Neutral Amino Acid Transporter That Associates with the 4F2 Heavy Chain and Exhibits Substrate Selectivity for Small Neutral d- and l-Amino Acids* , 2000, The Journal of Biological Chemistry.
[36] H. Takanaga,et al. Proton-Cotransport of Pravastatin Across Intestinal Brush-Border Membrane , 1995, Pharmaceutical Research.
[37] H. Takanaga,et al. MCT1-Mediated Transport of L-Lactic Acid at the Inner Blood–Retinal Barrier: A Possible Route for Delivery of Monocarboxylic Acid Drugs to the Retina , 2001, Pharmaceutical Research.
[38] A. Mitra,et al. Nasal absorption of tyrosine-linked model compounds. , 2001, Journal of pharmaceutical sciences.
[39] H. Daniel,et al. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. , 2002, American journal of physiology. Endocrinology and metabolism.
[40] E. Cordero,et al. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. , 2001, Investigative ophthalmology & visual science.
[41] Y. Tabata,et al. Biodegradable scleral plugs for vitreoretinal drug delivery. , 2001, Advanced drug delivery reviews.
[42] S. Dieck,et al. The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative β‐Ala‐Lys‐Nε‐AMCA in astrocytes , 1999 .
[43] J. Greenwood. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro , 1992, Journal of Neuroimmunology.
[44] C. Martini,et al. Importance of a Small N-Terminal Region in Mammalian Peptide Transporters for Substrate Affinity and Function , 2002, The Journal of Membrane Biology.
[45] J. Veuthey,et al. A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[46] E. Cordero,et al. Intravitreal, Retinal, and Central Nervous System Foscarnet Concentrations after Rapid Intravenous Administration to Rabbits , 2000, Antimicrobial Agents and Chemotherapy.
[47] S. Kawakami,et al. In situ ocular absorption of tilisolol through ocular membranes in albino rabbits. , 1996, Journal of pharmaceutical sciences.
[48] A. Alm,et al. Lactate transport through the blood-retinal and the blood-brain barrier in rats. , 1985, Ophthalmic research.
[49] B. Khoobehi,et al. INTRAVITREAL INJECTION OF LIPOSOME‐ENCAPSULATED GANCICLOVIR IN A RABBIT MODEL , 1987, Retina.
[50] F. Sirotnak,et al. Carrier-mediated membrane transport of folates in mammalian cells. , 1999, Annual review of nutrition.
[51] H. Neubauer,et al. Intestinal uptake of dipeptides and beta-lactam antibiotics. I. The intestinal uptake system for dipeptides and beta-lactam antibiotics is not part of a brush border membrane peptidase. , 1990, Biochimica et biophysica acta.
[52] K. Hosoya,et al. Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva. , 1998, Investigative ophthalmology & visual science.
[53] A. Mitra,et al. Prodrug based optimal drug delivery via membrane transporter/receptor , 2001, Expert opinion on biological therapy.
[54] W. T. Shults,et al. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. , 1986, American journal of ophthalmology.
[55] Y. Kanai,et al. Amino acid transporters: molecular structure and physiological roles. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[56] J. Holash,et al. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers , 1993, Brain Research.
[57] J. BotellaLlusiá,et al. [Long-term results]. , 1983, Anales de la Real Academia Nacional de Medicina.
[58] M. Grøndahl,et al. Transport of neutral, cationic and anionic amino acids by systems B, b(o,+), X(AG), and ASC in swine small intestine. , 2000, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.
[59] J. Rabkin,et al. Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients , 2000, Antimicrobial Agents and Chemotherapy.
[60] I. Constable,et al. Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis. , 1989, Investigative ophthalmology & visual science.
[61] D. Meredith,et al. Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1. , 2000, European journal of biochemistry.
[62] L. Rizzolo,et al. Regulation of glucose transporters during development of the retinal pigment epithelium. , 2000, Brain research. Developmental brain research.
[63] L. Rizzolo. Polarity and the development of the outer blood-retinal barrier. , 1997, Histology and histopathology.
[64] M. Refojo,et al. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. , 1997, Investigative ophthalmology & visual science.
[65] V. Ganapathy,et al. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina. , 1999, Investigative ophthalmology & visual science.
[66] W. Kramer,et al. Influence of amino acid side-chain modification on the uptake system for beta-lactam antibiotics and dipeptides from rabbit small intestine. , 1990, Biochimica et biophysica acta.
[67] E. Nagelhus,et al. Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat , 1999, Neuroscience.
[68] E. Wright,et al. Specificity of the Na+-dependent monocarboxylic acid transport pathway in rabbit renal brush border membranes , 2005, The Journal of Membrane Biology.
[69] R. Ramsay,et al. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. , 1989, Ophthalmology.
[70] P. Gastaud,et al. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[71] A. Mitra,et al. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[72] K. Dutt,et al. Nucleoside transport sites in a cultured human retinal cell line established by SV-40 T antigen gene. , 1994, Current eye research.
[73] S. W. Siegner,et al. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[74] H. Takanaga,et al. pH‐Dependent and Carrier‐mediated Transport of Salicylic Acid Across Caco‐2 Cells , 1994, The Journal of pharmacy and pharmacology.
[75] Q. Smith. Drug delivery to brain and the role of carrier-mediated transport. , 1993, Advances in experimental medicine and biology.
[76] N. Price,et al. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.
[77] W. Freeman,et al. Cytomegalovirus retinitis and response to therapy with ganciclovir. , 1987, Ophthalmology.
[78] R. Gurny,et al. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. , 2002, Investigative ophthalmology & visual science.
[79] L. Hubbard,et al. High dose oral ganciclovir treatment for cytomegalovirus retinitis. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[80] B. S. Costabile. Treatment of cytomegalovirus retinitis with intraocular implants. , 1998, AORN journal.
[81] Wolfgang Sadee,et al. 5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter , 1998, Pharmaceutical Research.
[82] W. Pardridge,et al. Neutral amino acid transport at the human blood-brain barrier. , 1986, Federation proceedings.
[83] T. Terasaki,et al. Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids. , 1990, Journal of pharmacobio-dynamics.
[84] V. Ganapathy,et al. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. , 1997, Biochemistry.
[85] J. Cunha-Vaz. The blood-retinal barriers , 1976, Documenta Ophthalmologica.
[86] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[87] D. Pow. Amino acids and their transporters in the retina , 2001, Neurochemistry International.
[88] A. Antony,et al. The biological chemistry of folate receptors. , 1992, Blood.